News
ACoP Phoenix 2024: A First-Time Experience to Remember!
We had a fantastic experience at ACoP in Phoenix, AZ! It was our first time exhibiting, and we were blown away by the incredible engagement and enthusiasm from everyone we met – from the brilliant pharma representatives to the academics, PhD candidates and postdocs. A...
Csaba Katai’s Latest Paper on FcRn Mechanism and Antibody Clearance
We are thrilled to share the latest paper of our mathematical modeler, Csaba Katai, on the neonatal Fc receptor (FcRn) regulated clearance mechanism for antibodies. The work not only contributes to the larger physiology-based pharmacokinetic models published in the...
Learn About In-Vitro to In-Vivo Translation and Drug Clearance in Our Latest Article
Would you like to learn more about drug clearance and how in-vitro to in-vivo translation generates insights about liver metabolism in drug development? We explain ins and outs of in-vitro to in-vivo correlation to predict human drug clearance in our latest article....
Celebrating 10 Years of PD-value: A Milestone Symposium and Future Insights
We are thrilled to mark a significant milestone - our 10-year anniversary! 🎉 Over the past decade, PD-value has grown into a trusted partner in pharmacometric and systems biology modeling, advancing drug development. To commemorate this occasion, we hosted a special...
CEO Jeroen Elassaiss-Schaap Featured in Immunowatch: Accelerating Antibody Development
We are ecstatic to share the news that our CEO, Jeroen Elassaiss-Schaap, has penned an exceptional article that was featured in the 10th edition of Immunowatch by MabDesign, the French biotech&pharma industry association.The article titled "Accelerating Antibody...
Join Our Beta Testing: Revolutionize PK-PD Modeling with IMPRES-M®!
If you are a PK-PD modeler who wants to try a new approach to accelerate your modeling efforts, look no further! Join us as a beta tester to revolutionize your research process. We are thrilled to introduce IMPRES-M®, a novel statistical method that redefines PK-PD...
PAGE 2024 in Rome: A Memorable Experience for the PD-value Team
We closed PAGE 2024 in Rome with a great experience and unforgettable memories.The PD-value team had an incredible time at PAGE 2024 in Rome. With a focus on pharmacometrics, we had the chance to interact with almost 1200 attendees from around the world. We thoroughly...
Season’s Greetings
We are celebrating yet another Holiday Season with festivities in many cultures all around the world. It is, therefore, a special time of the year for many of us. For many people and very often for organizations, it is also the time to reflect on the past year and our...
PD-value attended the “FD-Gazellen” announcement event in Amsterdam
On October 31st, we announced that PD-value is among the FD Gazellen this year. Last Thursday, Het Financieele Dagblad announced that we ranked 12th among the SMEs in the East region and 84th among the 1003 Gazellen, the fastest-growing companies, in the Netherlands....
PD-value is announced among the “FD-Gazellen” by “Het Financieele Dagblad”
We are happy to announce that PD-value is one of “FD Gazellen” this year! FD Gazellen is awarded by “Het Financieele Dagblad”, a Dutch Financial Newspaper, to the fast-growing Dutch Companies. We are honored to be among the selected group. We will continue to put our...
Want to know more?
For further introductions or to explore avenues of collaboration, please send an e-mail to jeroen@pd-value.com or see the contact page for other communication options.